Anti-Diabetic Agents
Browse ingredients, then choose a strength and product. Ontario inventory only; not a treatment recommendation.
GLICLAZIDE: products 1 to 19 of 19.
Prices below are the ministry's recorded amounts per source unit, not pharmacy quotes or the patient's payment. Different strengths, forms and package units are not directly comparable. The cost plan asks for quantity and refill details.
| Product / strength / form | Ontario listing | Recorded ministry price | Next step |
|---|---|---|---|
| Apo-Gliclazide 80mg TabDIN 02245247 | General benefit | $0.0931per source unit | Requirements & sourcesBuild cost plan |
| Apo-Gliclazide MR 30mg SR TabDIN 02297795 | General benefit | $0.0931per source unit | Requirements & sourcesBuild cost plan |
| Apo-Gliclazide MR 60mg ER TabDIN 02407124 | General benefit | $0.0632per source unit | Requirements & sourcesBuild cost plan |
| Diamicron 80mg TabDIN 00765996 | Listed, not a benefit | No price in this record | Requirements & sourcesBuild cost plan |
| Diamicron MR 30mg SR TabDIN 02242987 | General benefit | $0.0931per source unit | Requirements & sourcesBuild cost plan |
| Diamicron MR 60mg ER TabDIN 02356422 | General benefit | $0.0632per source unit | Requirements & sourcesBuild cost plan |
| Gliclazide 80mg TabDIN 02287072 | General benefit | $0.0931per source unit | Requirements & sourcesBuild cost plan |
| Gliclazide MR 30mg SR TabDIN 02524856 | General benefit | $0.0931per source unit | Requirements & sourcesBuild cost plan |
| Gliclazide MR 60mg ER TabDIN 02524864 | General benefit | $0.0632per source unit | Requirements & sourcesBuild cost plan |
| Jamp Gliclazide MR 30mg SR TabDIN 02429764 | General benefit | $0.0931per source unit | Requirements & sourcesBuild cost plan |
| Jamp Gliclazide-MR 60mg ER TabDIN 02429772 | General benefit | $0.0632per source unit | Requirements & sourcesBuild cost plan |
| Mint-Gliclazide MR 30mg SR TabDIN 02423286 | General benefit | $0.0931per source unit | Requirements & sourcesBuild cost plan |
| Mint-Gliclazide MR 60mg ER TabDIN 02423294 | General benefit | $0.0632per source unit | Requirements & sourcesBuild cost plan |
| Mylan-Gliclazide MR 30mg SR TabDIN 02438658 | General benefit | $0.0931per source unit | Requirements & sourcesBuild cost plan |
| Sandoz Gliclazide MR 30mg SR TabDIN 02461323 | General benefit | $0.0931per source unit | Requirements & sourcesBuild cost plan |
| Sandoz Gliclazide MR 60mg ER TabDIN 02461331 | General benefit | $0.0632per source unit | Requirements & sourcesBuild cost plan |
| Taro-Gliclazide MR 30mg SR TabDIN 02463571 | General benefit | $0.0931per source unit | Requirements & sourcesBuild cost plan |
| Taro-Gliclazide MR 60mg ER TabDIN 02439328 | General benefit | $0.0632per source unit | Requirements & sourcesBuild cost plan |
| Teva-Gliclazide 80mg TabDIN 02238103 | General benefit | $0.0931per source unit | Requirements & sourcesBuild cost plan |
Not seeing a product? Search Canadian records by medication name or DIN. Absence from this Ontario extract does not establish non-coverage. Open an exact product for its dated Health Canada status; a listing is not a stock check.
Class sources and program rules
Ontario Ministry of Health: odb-formulary-ed43-extract-2026-08-26.xml, extract 2026-08-26. Ontario class index: formulary-ed43-front-matter.txt, Part V.
68:20:02 Oral Anti-Diabetic Agents.
68:20:06 Incretin Mimetics.
68:20:10 Insulins (Rapid Acting).
68:20:12 Insulins (Intermediate Acting).
68:20:14 Insulins (Long Acting).
68:20:16 Insulins (Pre-Mixed).